A detailed history of Schear Investment Advisers, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Schear Investment Advisers, LLC holds 6,463 shares of NVO stock, worth $663,297. This represents 0.49% of its overall portfolio holdings.

Number of Shares
6,463
Previous 5,759 12.22%
Holding current value
$663,297
Previous $822,000 6.45%
% of portfolio
0.49%
Previous 0.61%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $83,825 - $102,375
704 Added 12.22%
6,463 $769,000
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $105,039 - $125,754
856 Added 17.46%
5,759 $822,000
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $500,645 - $666,415
4,903 New
4,903 $629,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Schear Investment Advisers, LLC Portfolio

Follow Schear Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schear Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schear Investment Advisers, LLC with notifications on news.